Benzinga | Oct 29, 2020 08:27AM EDT

Canaccord Genuity Maintains Buy on Teladoc Health, Raises Price Target to $261

Canaccord Genuity maintains Teladoc Health (NYSE:TDOC) with a Buy and raises the price target from $255 to $261.